Positive Minds, Strong Joints for Knee Osteoarthritis
(PMSJ Trial)
Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: Boston University Charles River Campus
No Placebo Group
Trial Summary
What is the purpose of this trial?
The aim of this research study is to test the feasibility of a physical and mental health intervention (Positive Minds, Strong Joints or PMSJ) for Black adults with knee osteoarthritis (OA).
Research Team
Eligibility Criteria
This trial is for Black adults over 50 with knee osteoarthritis, living in specific Boston neighborhoods, and receiving care at BMC or a CHC. Participants must have moderate to severe knee pain, a BMI ≤ 40 kg/m2, and show signs of depression or anxiety. They need to be available for the study duration and intervention sessions, and speak English well enough to understand the procedures.Inclusion Criteria
I live in Dorchester, Roxbury, Hyde Park, or Mattapan in Boston.
I can speak and understand English well enough to follow study instructions.
I identify as Black or African American.
See 7 more
Treatment Details
Interventions
- Positive Minds, Strong Joints (Behavioral Intervention)
Trial OverviewThe 'Positive Minds Strong Joints' program combines physical and mental health strategies specifically designed for Black adults with knee osteoarthritis. The study tests how feasible this approach is by monitoring participants' adherence and response to the intervention.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Positive Minds Strong JointsExperimental Treatment1 Intervention
Participants will receive an individual mental health intervention through a zoom video-call once a week for 10 weeks and a community-based group exercise intervention once a week for 10 weeks.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor
Trials
125
Recruited
14,100+
Dr. Melissa Gilliam
Boston University Charles River Campus
Chief Executive Officer
MD from Yale School of Medicine
Dr. Alastair Bell
Boston University Charles River Campus
Chief Medical Officer since 2023
MD from Harvard Medical School
Rheumatology Research Foundation
Collaborator
Trials
14
Recruited
8,200+